Photo (c) Iryna Drozd – Getty Images

The U.S. Food and Drug Administration (FDA) has sent warning letters to four companies that the agency says are illegally selling honey products that may pose a significant health risk to consumers.

The warning letters were sent to Thirstyrun LLC, also known as US Royal Honey LLC; MKS Enterprise LLC; Shopaax.com; and 1am USA Incorporated, dba Pleasure Products USA.

The FDA said its lab found samples of the four companies’ products contained active drug ingredients that were not listed on product labels, including active drug ingredients found in Cialis (tadalafil) and Viagra (sildenafil), which are FDA approved drugs. used to treat men with erectile dysfunction.

Potentially dangerous interactions

Sildenafil and tadalafil are prescription drugs, so they can only be used if supplied by a licensed healthcare professional. The agency said the potential risks are significant.

For example, it says undeclared ingredients can interact with nitrates found in some prescription drugs, such as nitroglycerin, and can lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

“Contaminated honey products like these are dangerous because consumers are likely unaware of the risks associated with the hidden ingredients of prescription drugs in these products and how they may interact with other drugs and supplements they can take,” the FDA’s associate commissioner for regulatory affairs said. Judy McMeekin.

McMeekin says the unidentified ingredients are not only dangerous, but can prove deadly in some cases.

“We encourage consumers to remain vigilant when shopping online or in stores to avoid purchasing products that put their health at risk, and instead seek out effective FDA-approved treatments,” she said. declared.

The warning letters informed the companies that it was a violation of federal law to market a product as a food when it also contained active medicinal ingredients. According to the FDA, the companies were likely aware of the medicinal properties of their products, as they are marketed for “sexual enhancement” on various websites, online marketplaces, and possibly in some retail stores.

The FDA ordered the four companies to respond to the letter within 15 days and present evidence to show the products do not violate US law.